No insider purchases or sales are on record for NUTRA PHARMA CORP in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
no 13F holders found for this ticker
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $257.6K | $246.3K | $205.6K | $145.8K |
| GROSS PROFIT | $196.6K | $247.3K | $396.5K | $249.0K |
| OPERATING INCOME | $-1.5M | $-878.4K | $-887.0K | $-1.9M |
| NET INCOME | $-2.0M | $-1.3M | $-1.4M | $8.2M |
| EPS (DILUTED) | 0.00 | 0.00 | 0.00 | 0.00 |
| OPERATING CASH FLOW | $-1.2M | $-424.0K | $-550.0K | $-762.4K |
| CASH | $12.2K | $36.4K | $0 | $0 |
| LONG-TERM DEBT | $136.6K | $140.2K | $143.7K | $8.2M |
No password to create and no card required. We store your email address and nothing else.